Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron treatment in iron-deficient idiopathic pulmonary arterial hypertension patients
2010-023233-30Phase 4Active
- Sponsor
- VU university medical center
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ferric carboxymaltose in Plexogenic Pulmonary Arteriopathy and iron deficiency anemia (IDA), sponsored by VU university medical center. Primary endpoint: Six-minute walk distance. Started Oct 2010; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
Plexogenic Pulmonary Arteriopathyiron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2010-023233-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023233-30.